STEREOTACTIC BODY RADIATION THERAPY AND ABIRATERONE ACETATE FOR PATIENTS AFFECTED BY OLIGOMETASTATIC CASTRATERESISTANT PROSTATE CANCER: A RANDOMIZED PHASE II TRIAL (ARTO-NCT03449719)

被引：0
|
作者：
Francolini, Giulio [1 ]
Allegra, Andrea Gaetano [2 ]
Caini, Saverio [3 ]
Di Cataldo, Vanessa [1 ]
Detti, Beatrice [1 ]
Alitto, Anna Rita [4 ]
Parisi, Silvana [5 ]
D'angelillo, Rolando Maria [6 ]
Bruni, Alessio [7 ]
Ingrosso, Gianluca [8 ]
Augugliaro, Matteo [9 ]
Lorenzetti, Victoria [2 ]
Orsatti, Carolina [2 ]
Caprara, Luisa [2 ]
Frosini, Giulio [2 ]
Burchini, Luca [2 ]
Lapini, Alberto [10 ]
Triggiani, Luca [11 ]
Desideri, Isacco [2 ]
Meattini, Icro [2 ]
Livi, Lorenzo [2 ]
机构：
[1] Azienda Osped Univ Careggi, Dept Oncol, Radiat Oncol Unit, Florence, Italy
[2] Univ Florence, M Serio Dept Biomed Expt & Clin Sci, Florence, Italy
[3] Inst Canc Res Prevent & Clin Network ISPO, Canc Risk Factors & Lifestyle Epidemiol Unit, Florence, Italy
[4] A Gemelli Policlin Univ, UOC Radioterapia Oncol, Rome, Italy
[5] Univ Messina, Radiat Oncol Unit, Messina, Italy
[6] Univ Roma Tor Vergata, Dept Biomed & Prevent, Radiat Oncol, Rome, Italy
[7] Univ Hosp Modena, Dept Hematol & Oncol, Radiat Oncol Unit, Modena, Italy
[8] Univ Perugia, Radiat Oncol Sect, Dept Med & Surg, Perugia, Italy
[9] Azienda USL IRCCS Reggio Emilia, Unit Radiotherapy, Reggio Emilia, Italy
[10] Univ Florence, Dept Urol, Florence, Italy
[11] Univ Brescia, Dept Radiat Oncol, Brescia, Italy
来源：
ANTICANCER RESEARCH | 2023年 / 43卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
28
引用
收藏
页码：4764 / 4765
页数：2
相关论文
共 50 条
  • [21] Clinical Outcomes with Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer: Results from a Prospective Registry Trial
    Lee, K. N.
    Chen, Y. H.
    Kang, H.
    Doyle, P.
    Pomerantz, M.
    Ravi, P.
    Choudhury, A. D.
    Kozono, D. E.
    Balboni, T. A.
    Spektor, A.
    Huynh, M. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E126 - E128
  • [22] Stereotactic body radiation therapy (SBRT) delays the emergence of castration resistance in patients with oligometastatic prostate cancer
    M. I. Martínez-Fernández
    J. L. Pérez Gracia
    I. Gil-Bazo
    R. Martínez-Monge
    Clinical and Translational Oncology, 2016, 18 : 743 - 747
  • [23] PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patients
    Francolini, Giulio
    Porreca, Angelo
    Facchini, Gaetano
    Santini, Daniele
    Bruni, Alessio
    Simoni, Nicola
    Trovo, Marco
    Osti, Mattia Falchetto
    Fornarini, Giuseppe
    Sisani, Michele
    Di Cataldo, Vanessa
    Detti, Beatrice
    Garlatti, Pietro
    Bertini, Niccolo
    Serni, Sergio
    Minervini, Andrea
    Livi, Lorenzo
    MEDICAL ONCOLOGY, 2023, 41 (01)
  • [24] PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative “triplet” for oligometastatic hormone sensitive prostate cancer patients
    Giulio Francolini
    Angelo Porreca
    Gaetano Facchini
    Daniele Santini
    Alessio Bruni
    Nicola Simoni
    Marco Trovò
    Mattia Falchetto Osti
    Giuseppe Fornarini
    Michele Sisani
    Vanessa Di Cataldo
    Beatrice Detti
    Pietro Garlatti
    Niccolò Bertini
    Sergio Serni
    Andrea Minervini
    Lorenzo Livi
    Medical Oncology, 41
  • [25] Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial
    Jaccard, Maud
    Zilli, Thomas
    Dubouloz, Angele
    Escude, Lluis
    Jorcano, Sandra
    Linthout, Nadine
    Brat, Samuel
    Verbakel, Wilko
    Bruynzeel, Anna
    Bjorkqvist, Mikko
    Minn, Heikki
    Tsvang, Lev
    Symon, Zvi
    Lencart, Joana
    Oliveira, Angelo
    Ozen, Zeynep
    Abacioglu, Ufuk
    Perez-Moreno, Juan Maria
    Rubio, Carmen
    Rouzaud, Michel
    Miralbell, Raymond
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (04): : 1047 - 1054
  • [26] Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer The ORIOLE Phase 2 Randomized Clinical Trial
    Phillips, Ryan
    Shi, William Yue
    Deek, Matthew
    Radwan, Noura
    Lim, Su Jin
    Antonarakis, Emmanuel S.
    Rowe, Steven P.
    Ross, Ashley E.
    Gorin, Michael A.
    Deville, Curtiland
    Greco, Stephen C.
    Wang, Hailun
    Denmeade, Samuel R.
    Paller, Channing J.
    Dipasquale, Shirl
    DeWeese, Theodore L.
    Song, Daniel Y.
    Wang, Hao
    Carducci, Michael A.
    Pienta, Kenneth J.
    Pomper, Martin G.
    Dicker, Adam P.
    Eisenberger, Mario A.
    Alizadeh, Ash A.
    Diehn, Maximilian
    Tran, Phuoc T.
    JAMA ONCOLOGY, 2020, 6 (05) : 650 - 659
  • [27] A Phase 1 Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer
    Patel, Krishnan R.
    Md, Nicholas R. Rydzewski
    Schott, Erica
    Cooley-Zgela, Theresa
    Ning, Holly
    Cheng, Jason
    Salerno, Kilian
    Huang, Erich P.
    Pinto, Peter A.
    Lindenberg, Liza
    Mena, Esther
    Choyke, Peter
    Turkbey, Baris
    Citrin, Deborah E.
    PRACTICAL RADIATION ONCOLOGY, 2023, 13 (06) : 540 - 550
  • [28] A Phase I Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer
    Patel, K.
    Rydzewski, N. R.
    Schott, E. E.
    Cooley-Zgela, T. C.
    Ning, H.
    Cheng, J. Y.
    Pinto, P. A.
    Salerno, K. E.
    Lindenberg, L.
    Mena, E.
    Turkbey, B.
    Choyke, P.
    Citrin, D. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E426 - E427
  • [29] Focal radiation for oligometastatic castration-resistant prostate cancer (FORCE): A phase II randomized trial.
    Reichert, Zachery
    Smith, David C.
    Morgan, Todd Matthew
    Piert, Morand
    Tomlins, Scott A.
    Cackowski, Frank Cameron
    Caram, Megan Veresh
    Hearn, Jason W. D.
    Palmbos, Phillip Lee
    Schonewolf, Caitlin
    Yentz, Sarah Elizabeth
    Spratt, Daniel Eidelberg
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] Re: Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial
    Augugliaro, Matteo
    Pepa, Matteo
    Marvaso, Giulia
    Jereczek-Fossa, Barbara Alicja
    EUROPEAN UROLOGY, 2021, 79 (06) : 889 - +
12345